| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.1 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.099 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |